Curetis Files for U.S. FDA 510(k) Clearance of Unyvero LRT for BAL Specimens

24 July 2019

Curetis N.V., a developer of next-level molecular diagnostic solutions, today announced it has submitted a 510(k) application to the U.S. Food and Drug Administration for its Unyvero LRT Lower Resp